Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in citrullinemia

Metabolism: Clinical and Experimental

Volumn 55, Issue 12, 2006, Pages 1599-1603

  Lücke, Thomas ^a   Tsikas, Dimitrios ^a   Kanzelmeyer, Nele ^a   Vaske, Bernhard ^a   Das, Anibh Martin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CITRULLINE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; ARTICLE; CITRULLINEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INFANT; NEWBORN; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ARGININE; CITRULLINEMIA; ENZYME INHIBITORS; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 35648966680     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.07.020     Document Type: Article

References (23)

1. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). Metabolic and molecular bases of inherited diseases. 8th ed. (2001), Mc Graw-Hill, New York 1929-1949
2. Tokatli A., Coskun T., and Ozalp I. Citrullinemia. Clinical experience with 23 cases. Turk J Pediatr 40 (1998) 185-193
3. Husson A., Brasse-Lagnel C., Fairand A., Renouf S., and Lavoinne A. Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. Eur J Biochem 270 (2003) 1887-1899
4. Marletta M.A. Nitric oxide synthase structure and mechanism. J Biol Chem 268 (1993) 12231-12234
5. Vallance P., Leon A., Calver A., Collier J., and Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 20 (1992) 60-62
6. Tsikas D., Böger R.H., Sandmann J., Bode-Böger S.M., and Frölich J.C. Endogenous nitric oxide synthase inhibitors are responsible for the l-arginine paradox. FEBS Lett 478 (2000) 1-3
7. Leiper J.M., and Vallance P. The synthesis and metabolism of asymmetric dimethylarginine (ADMA). Eur J Clin Pharmacol 62 (2006) 33-38
8. Mc Dermott J.R. Studies on the catabolism of Ng-methylarginine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine in the rabbit. Biochem J 154 (1976) 179-184
9. Achan V., Broadhead M., Malaki M., Whitley G., Leiper J., MacAlister R., et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23 (2003) 1455-1459
10. Cooke J.P., and Dzau V.J. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 48 (1997) 489-509
11. Tsikas D., Gutzki F.M., and Stichtenoth D.O. Circulating and excretory nitrite and nitrate as indicators of nitric oxide synthesis in humans: methods of analysis. Eur J Clin Pharmacol 62 (2006) 51-59
12. Tsikas D., Schubert B., Gutzki F.M., Sandmann J., and Frölich J.C. Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri(N-pentafluoropropionyl) derivative. J Chromatogr B 798 (2003) 87-99
13. Tsikas D. Simultaneous derivatization and quantification of the nitric oxide metabolites nitrite and nitrate in biological fluids by gas chromatography-mass spectrometry. Anal Chem 72 (2000) 4064-4072
14. Tsikas D., Wolf A., and Frölich J.C. Simplified HPLC method for urinary and circulating creatinine. Clin Chem 50 (2004) 201-203
15. Ripley B.D., French B.J., and Edgington L.V. Gas chromatographic determination of primary and secondary amines as pentafluorobenzamide derivatives. J Assoc Off Anal Chem 65 (1982) 1066-1072
16. Böger R.H., Bode-Böger S.M., Thiele W., Junker W., Alexander K., and Frölich J.C. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95 (1997) 2068-2074
17. Martens-Lobenhoffer J., and Bode-Böger S.M. Measurement of asymmetric dimethylarginine (ADMA) in human plasma: from liquid chromatography estimation to liquid chromatography-mass spectrometry quantification. Eur J Clin Pharmacol 62 (2006) 61-68
18. Kielstein J.T., Tsikas D., and Fliser D. Effects of asymmetric dimethylarginine (ADMA) infusion in humans. Eur J Clin Pharmacol 62 (2006) 39-44
19. McMurray W.C., Mohyuddin F., and Rossiter R.M. Citrullinuria, a new aminoaciduria associate with mental retardation. Lancet 1 (1962) 138
20. Kakimoto Y., Matsuoka Y., Miyake M., and Konishi H. Methylated amino acid residues of proteins of brain and other organs. J Neurochem 24 (1975) 893-902
21. Moncada S., and Higgs E.A. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 147 Suppl 1 (2006) S193-S201
22. Ischiropoulos H., and Beckman J.S. Oxidative stress and nitration in neurotoxicity: cause, effect or association?. J Clin Invest 111 (2003) 163-169
23. Martin J.J., Farriaux J.P., and De Jonghe P. Neuropathology of citrullinemia. Acta Neuropathol 56 (1982) 303-306